Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

Glioblastoma is the most aggressive and lethal primary brain malignancy, with an average patient survival from diagnosis of 14 months. Glioblastoma also usually progresses as a more invasive phenotype after initial treatment. A major step forward in our understanding of the nature of glioblastoma wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zottel, Alja, Šamec, Neja, Videtič Paska, Alja, Jovčevska, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409010/
https://www.ncbi.nlm.nih.gov/pubmed/32650527
http://dx.doi.org/10.3390/cancers12071842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409010/
https://www.ncbi.nlm.nih.gov/pubmed/32650527
http://dx.doi.org/10.3390/cancers12071842

Ejemplares similares